Deep brain stimulation (DBS) of the subthalamic nucleus (STN) dramatically improves motor function and quality of life in PD yet may alter cognitive skills and mood (Progress Report). Our studies and others suggest that functional organization of basal ganglia-thalamocortical (BGTC) circuits and their course through STN underlies these effects. We hypothesize based on preliminary data that DBS focused in ventral STN (V-STN) selectively alters cognition and mood whereas motor benefit is widely distributed. We propose that this functional organization of STN will produce downstream effects in relevant pathways. In people with PD, we will compare the effects of unilateral monopolar DBS through selected V-STN and dorsal STN (D-STN) contacts on quantified motor, cognitive, and mood function with DBS-induced rCBF responses and presurgical MRI-based resting state functional connectivity (rs-fcMRI) networks. We found that rs-fcMRI identified key cortical and BGTC networks that are disrupted in PD and can provide an anchor for interpretation of downstream effects seen with rCBF responses. These studies have great potential to extend our understanding of the functional anatomy of the STN by delineating its role in motor, cognitive and mood behaviors in PD. These studies could reveal valuable insights into the clinical action of DBS and the pathophysiology of cognitive, mood and motor symptoms of PD. However, the importance of these studies goes beyond the specifics of DBS treatment for PD. We can take this unique opportunity to investigate the function of selected brain pathways in the region of the STN and how they affect cognitive, mood and motor function. Such basic observations have importance for understanding STN function and how impairments lead to disabilities in other basal ganglia disorders. These studies also have the potential to help refine DBS targeting, inform future development of new electrode design to shape current spread and improve programming strategies for optimal clinical benefit from STN DBS.
Parkinson disease (PD) affects nearly one million people in North American and leads to substantial disability for many. Deep brain stimulation (DBS) has been a dramatic advance, yet there are still many unknowns about how this new therapy works. This proposal has the potential to reveal valuable insights into the clinical action of DBS and the pathophysiology of non-motor as well as motor manifestations of PD. However, the importance of these studies goes well beyond the specifics of DBS treatment for PD. We also can take advantage of this unique opportunity to investigate the function of selected brain pathways and how they affect cognitive, mood and motor function. Such basic observations have importance for understanding normal function as well as how impairments lead to disabilities in other basal ganglia related disorders with motor or cognitive dysfunction.
|Buddhala, Chandana; Campbell, Meghan C; Perlmutter, Joel S et al. (2015) Correlation between decreased CSF ?-synuclein and A????? in Parkinson disease. Neurobiol Aging 36:476-84|
|Norris, Scott A; Derdeyn, Colin P; Perlmutter, Joel S (2015) Levodopa-responsive hemiparkinsonism secondary to cystic expansion from a coiled cerebral aneurysm. J Neuroimaging 25:316-8|
|Willis, Allison W; Schootman, Mario; Kung, Nathan et al. (2014) Disparities in deep brain stimulation surgery among insured elders with Parkinson disease. Neurology 82:163-71|
|Eisenstein, Sarah A; Dewispelaere, William B; Campbell, Meghan C et al. (2014) Acute changes in mood induced by subthalamic deep brain stimulation in Parkinson disease are modulated by psychiatric diagnosis. Brain Stimul 7:701-8|
|Peterson, Daniel S; Pickett, Kristen A; Duncan, Ryan P et al. (2014) Brain activity during complex imagined gait tasks in Parkinson disease. Clin Neurophysiol 125:995-1005|
|Eisenstein, Sarah A; Koller, Jonathan M; Black, Kathleen D et al. (2014) Functional anatomy of subthalamic nucleus stimulation in Parkinson disease. Ann Neurol 76:279-95|
|Peterson, Daniel S; Pickett, Kristen A; Duncan, Ryan et al. (2014) Gait-related brain activity in people with Parkinson disease with freezing of gait. PLoS One 9:e90634|
|Perlmutter, Joel S (2014) Comment: fMRI biomarker for premanifest HD? Neurology 83:71|
|Hershey, Linda A; Perlmutter, Joel S (2014) Smoking and Parkinson disease: where there is smoke there may not be fire. Neurology 83:1392-3|
|Perlmutter, Joel S; Norris, Scott A (2014) Neuroimaging biomarkers for Parkinson disease: facts and fantasy. Ann Neurol 76:769-83|
Showing the most recent 10 out of 85 publications